Sort   by:  
 Page size 
UnknownProcalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients.
Not available
S-EPMC10425511 | biostudies-literature
UnknownCD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Not available
S-EPMC10926187 | biostudies-literature
UnknownLenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Not available
S-EPMC9433956 | biostudies-literature
UnknownStrategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review.
Not available
S-EPMC8403456 | biostudies-literature
UnknownDeploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain.
Not available
S-EPMC7883885 | biostudies-literature
UnknownRemdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study.
Not available
S-EPMC9804970 | biostudies-literature
UnknownFalls Predict Acute Hospitalization in Parkinson's Disease.
Not available
S-EPMC9912731 | biostudies-literature
UnknownIdentifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease.
Not available
S-EPMC8653592 | biostudies-literature
UnknownPredictors of clinically significant quality of life impairment in Parkinson's disease.
Not available
S-EPMC8677846 | biostudies-literature
UnknownEffectiveness and Safety of Teriflunomide in Relapsing-Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study.
Not available
S-EPMC10630277 | biostudies-literature
Sort   by:  
 Page size